Abstract:Background MRI is of increasing importance in the diagnostic evaluation of gastrointestinal diseases, with depiction of mucosal enhancement obtained with conventional intravenous contrast. Routine clinical use of contrast agents has been carried out using intravenous injection for mucosal imaging. Contrast agents that specifically target the intestinal mucosa are therefore needed to improve clinical imaging of the mucosal surface. Purpose To synthesize a novel contrast agent for gadopentetic acid (Gd-DTPA)-loaded chitosan nanoparticles and observe the absorption of the nanoparticles in the colon wall of healthy rats by MR imaging in vivo. Material and Methods A contrast agent was successfully synthesized by a modified emulsion coalescence method, and the resulting agents were characterized in detail by dynamic light-scattering spectroscopy and inductively coupled plasma emission spectroscopy. The cytotoxicity of Gd-chitosan nanoparticles was evaluated by an MTT assay. Gadolinium-chitosan (Gd@chitosan) nanoparticles were administered to the colon mucosa of healthy rats by rectal administration, and MRI scans in vivo were carried out with a 3.0 T imaging scanner at various time points. Results The prepared Gd@chitosan nanoparticles were ∼420 nm in diameter with a 74.4% Gd-DTPA content. The MTT assay indicated little cytotoxicity. MRI results showed that nanoparticles can be retained in both the stratum submucosum and epithelial cells of the colon for almost 80 min. Transmission electron microscopy images further revealed that Gd@chitosan nanoparticles were localized inside the mucosal cells or intercellular space, while tissue from Gd-DTPA aqueous solution administration showed nothing. Due to the infusion of Gd@chitosan nanoparticles, the MR signal intensity of colon mucosa increased from about 6% to 35%, and the contrast enhancement was highest at 20 min after administration. Conclusion Gd@chitosan nanoparticles with high Gd-DTPA content were successfully prepared for use as a novel MRI contrast agent. All results indicated that rectally administered Gd@chitosan nanoparticles have the potential for MRI diagnosis of colon mucosal disease.

Preparation and in Vitro Evaluation of a Gadolinium-Containing Vitamin E TPGS Micelle As a Potential Contrast Agent for MR Imaging

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Gadolinium-based contrast agents for tumor targeting imaging

A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox‐sensitive biodegradable macromolecular MRI contrast agent

Preparation and in Vitro Evaluation of a MRI Contrast Agent Based on Aptamer-Modified Gadolinium-Loaded Liposomes for Tumor Targeting

Gadolinium-chitosan Nanoparticles As a Novel Contrast Agent for Potential Use in Clinical Bowel-Targeted MRI: a Feasibility Study in Healthy Rats.

Fabrication and Evaluation of Tumor-Targeted Positive MRI Contrast Agent Based on Ultrasmall MnO Nanoparticles.

Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent

Oligoethylenimine-Grafted Chitosan As Enhanced T-1 Contrast Agent for in Vivo Targeted Tumor Mri

Preparation and performance of biocompatible gadolinium polymer as liver-targeting magnetic resonance imaging contrast agent

Design, synthesis, and evaluation of VEGFR-targeted macromolecular MRI contrast agent based on biotin-avidin-specific binding.

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Gadolinium-Loaded Chitosan Nanoparticles As Magnetic Resonance Imaging Contrast Agents for the Diagnosis of Tumor

Intracellular Construction of Cathepsin B-Guided Gadolinium Nanoparticles for Enhanced T2 -Weighted MR Tumor Imaging.

Poly(glycerol) Used for Constructing Mixed Polymeric Micelles as T1 MRI Contrast Agent for Tumor-Targeted Imaging

Synthesis of PEGylated BaGdF5 Nanoparticles As Efficient CT/MRI Dual-modal Contrast Agents for Gastrointestinal Tract Imaging

Preparation of linear poly(glycerol) as a T1 contrast agent for tumor-targeted magnetic resonance imaging

Γ-Glutamyltranspeptidase-triggered Intracellular Gadolinium Nanoparticle Formation Enhances the T2-Weighted MR Contrast of Tumor

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

In Vitro Study of Novel Gadolinium-Loaded Liposomes Guided by GBI-10 Aptamer for Promising Tumor Targeting and Tumor Diagnosis by Magnetic Resonance Imaging

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor <i>T</i><sub>1</sub> Magnetic Resonance Imaging